Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Share Capital - Schedule of Options Granted to Employees and Directors (Details)

v3.25.1
Share Capital - Schedule of Options Granted to Employees and Directors (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Options Outstanding, Options outstanding at the beginning of the year 1,745,880    
Weighted average exercise price Options outstanding, Options outstanding at the beginning of the year $ 5.8    
weighted average remaining contractual term (in years), Options outstanding at the beginning of the year 5 years 10 months 28 days    
aggregate intrinsic value, Options outstanding at the beginning of the year $ 1,165    
Number of options, Granted 50,500    
Weighted average exercise price, Granted $ 5.15    
weighted average remaining contractual term (in years), Granted 8 years 6 months 25 days    
aggregate intrinsic value, Granted    
Number of options, Exercised (1,840)    
Weighted average exercise price, Exercised $ 5.07    
weighted average remaining contractual term (in years), Exercised    
aggregate intrinsic value, Exercised [1] $ 271 $ 221
Number of options, Expired (29,313)    
Weighted average exercise price, Expired $ 6.99    
weighted average remaining contractual term (in years), Expired    
aggregate intrinsic value, Expired    
Number of options, Forfeited (37,472)    
Weighted average exercise price, Forfeited $ 6.22    
weighted average remaining contractual term (in years), Forfeited    
aggregate intrinsic value, Forfeited    
Number of options, Options outstanding at the end of the year 1,727,755 1,745,880  
Weighted average exercise price, Options outstanding at the end of the year $ 5.75    
weighted average remaining contractual term (in years), Options outstanding at the end of the year 4 years 11 months 26 days    
aggregate intrinsic value, Options outstanding at the end of the year    
Number of options, Options exercisable at the end of the year 1,383,902    
Weighted average exercise price, Options exercisable at the end of the year $ 5.64    
weighted average remaining contractual term (in years), Options exercisable at the end of the year 4 years 3 months 7 days    
aggregate intrinsic value, Options exercisable at the end of the year    
Non-Employees [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Options Outstanding, Options outstanding at the beginning of the year 11,666    
Weighted average exercise price Options outstanding, Options outstanding at the beginning of the year $ 16.78    
weighted average remaining contractual term (in years), Options outstanding at the beginning of the year 1 year 4 months 9 days    
aggregate intrinsic value, Options outstanding at the beginning of the year $ 2    
Number of options, Granted 25,000    
Weighted average exercise price, Granted $ 4.46    
weighted average remaining contractual term (in years), Granted 9 years 9 months 10 days    
aggregate intrinsic value, Granted    
Number of options, Options outstanding at the end of the year 36,666 11,666  
Weighted average exercise price, Options outstanding at the end of the year $ 8.35    
weighted average remaining contractual term (in years), Options outstanding at the end of the year 6 years 9 months 10 days    
aggregate intrinsic value, Options outstanding at the end of the year    
Number of options, Options exercisable at the end of the year 6,329    
Weighted average exercise price, Options exercisable at the end of the year $ 9.95    
weighted average remaining contractual term (in years), Options exercisable at the end of the year 4 months 2 days    
aggregate intrinsic value, Options exercisable at the end of the year    
[1] Less than 1